Table 4 Pathway enrichment analysis of red gene module for drug treatment in NPCs.
Source | Term | Q value |
|---|---|---|
CORUM | AML1-HIPK2-p300 complex | 0.017 |
CORUM | EGR-EP300 complex | 0.023 |
CORUM | DNA polymerase alpha-primase complex | 0.042 |
CORUM | TNF-alpha/NF-kappa B signaling complex 9 | 0.043 |
GO:BP | cell morphogenesis | 9.93E−09 |
GO:BP | neuron development | 4.57E−07 |
GO:BP | neuron projection development | 7.92E−07 |
GO:BP | cell morphogenesis involved in differentiation | 2.46E−06 |
GO:BP | neuron differentiation | 3.78E−06 |
GO:BP | anatomical structure morphogenesis | 5.15E−06 |
GO:BP | generation of neurons | 5.51E−06 |
GO:BP | neurogenesis | 7.43E−06 |
GO:BP | cell projection morphogenesis | 4.04E−05 |
GO:BP | cellular component morphogenesis | 5.32E−05 |
GO:BP | cell part morphogenesis | 8.74E−05 |
GO:BP | plasma membrane bounded cell projection morphogenesis | 1.07E-04 |
GO:BP | nervous system development | 1.19E-04 |
GO:BP | neuron projection morphogenesis | 1.78E-04 |
GO:BP | cell morphogenesis involved in neuron differentiation | 3.17E-04 |
GO:BP | plasma membrane bounded cell projection organization | 3.18E-04 |
GO:BP | cell projection organization | 4.36E-04 |
GO:BP | morphogenesis of an epithelium | 8.95E-04 |
GO:BP | regulation of cell projection organization | 0.001 |
GO:BP | tissue morphogenesis | 0.001 |
GO:BP | regulation of plasma membrane bounded cell projection organization | 0.002 |
GO:BP | regulation of neuron projection development | 0.004 |
GO:BP | axon development | 0.004 |
GO:BP | cell development | 0.0067 |
GO:BP | system development | 0.006 |
GO:BP | positive regulation of cell projection organization | 0.023 |
GO:BP | axonogenesis | 0.027 |
GO:BP | regulation of anatomical structure morphogenesis | 0.033 |
GO:BP | developmental growth | 0.040 |
MIRNA | hsa-miR-218-5p | 0.002 |
REAC | Nervous system development | 0.013 |
REAC | Axon guidance | 0.033 |
REAC | Attenuation phase | 0.049 |
WP | Pathways Affected in Adenoid Cystic Carcinoma | 2.59E-04 |
WP | Mesodermal Commitment Pathway | 0.028 |
